Exclusive-China taps US AI models to train homegrown rivals as chip curbs bite Investing.com · News 35m ago
Cyclopharm at Bell Potter Healthcare Conference: U.S. growth accelerates Investing.com · News 45m ago
Novartis wins FDA approval for Cosentyx in polymyalgia rheumatica Investing.com · Investing_news 45m ago
A 450% revenue beat, a 20%+ gain: the biotech our AI models picked first Investing.com · Investing_news 1h ago